B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

P2RX1

MOLECULAR TARGET

purinergic receptor P2X 1

UniProt: P51575NCBI Gene: 50236 compounds

P2RX1 (purinergic receptor P2X 1) is targeted by 6 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting P2RX1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1imd 03542.8316
2pyridoxal phosphate anhydrous2.7114
3Adenosine Triphosphate1.102
4Pyridoxal Phosphate This is1.102
5Suramin1.102
6Adenosine Diphosphate Adenosine 5'-(trihydrogen diphosphate).0.691

About P2RX1 as a Drug Target

P2RX1 (purinergic receptor P2X 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 6 compounds with documented P2RX1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

P2RX1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.